Optimistic Buy Rating for Merck & Co. Driven by Winrevair Projections and Financial Strength
In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
Dalan Animal Health Taps Dr. Erin Strait to Drive Next Wave of Innovation as Chief Scientific Officer
Dalan Animal Health, a pioneering biotechnology company developing vaccines that leverage innate immunity, announced today ...
Contract Pharma2h
Touchlight Appoints Will Downie as Key Adviser
Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...
The Chronicle of Philanthropy1h
Former Scholarship Student Leaves $50 Million to Private School
Plus, Lodi Community Foundation lands a $30 million bequest, and the Ukrainian Catholic University Foundation gets millions ...
Le Lézard4h
NanoViricides Engages CRO for Phase II Clinical Trial
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial ...
Analysts Issue Forecasts for MRK FY2029 Earnings
Analysts at Leerink Partnrs issued their FY2029 EPS estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Friday, January 24th. Leerink Partnrs analyst D.
Le Lézard3h
The 2025 PDA Board of Directors: A Diverse Range of Interests and Expertise
PDA today released the names of its 2025 Board of Directors following fall elections by the membership. The officers and directors represent pharmaceutical/biopharmaceutical businesses of all sizes ...